According to Jazz Pharmaceuticals's latest financial reports the company has $3.52 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $3.08 B | -22.18% |
2021-12-31 | $3.96 B | 8.35% |
2020-12-31 | $3.65 B | 17.64% |
2019-12-31 | $3.11 B | 12.82% |
2018-12-31 | $2.75 B | 1.63% |
2017-12-31 | $2.71 B | 44.52% |
2016-12-31 | $1.87 B | 17.43% |
2015-12-31 | $1.59 B | 16.59% |
2014-12-31 | $1.37 B | 5.84% |
2013-12-31 | $1.29 B | 15.54% |
2012-12-31 | $1.12 B | 481.62% |
2011-12-31 | $0.19 B | 531.04% |
2010-12-31 | $30.55 M | -141.95% |
2009-12-31 | $-72.83 M | -21.59% |
2008-12-31 | $-92.88 M | -268.89% |
2007-12-31 | $54.99 M | -131.19% |
2006-12-31 | $-0.18 B | 49.09% |
2005-12-31 | $-0.12 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | $51.93 B | 1,372.94% | ๐จ๐ญ Switzerland |
![]() AmerisourceBergen
ABC | $0.92 B | -73.85% | ๐บ๐ธ USA |
![]() Endo International
ENDPQ | -$4.13 B | -217.06% | ๐ฎ๐ช Ireland |
![]() Teva Pharmaceutical Industries TEVA | $7.70 B | 118.62% | ๐ฎ๐ฑ Israel |